Sun Pharma Announce FDA Approval of Xelpros to Treat Open-angle Glaucoma or Ocular Hypertension

Sun Pharma Announce FDA Approval of Xelpros to Treat Open-angle Glaucoma or Ocular Hypertension

Submitted by admin on September 14, 2018 - 10:59am
Source: 
CP Wire
News Tags: 
Sun Pharma
Xelpros
latanoprost
open angle glaucoma
Headline: 
Sun Pharma Announce FDA Approval of Xelpros to Treat Open-angle Glaucoma or Ocular Hypertension
snippet: 
  • Xelpros is the first and only form of latanoprost that is not formulated with benzalkonium chloride (BAK)
  • BAK is associated with increased incidence of Ocular Surface Disease (OSD)

Do Not Allow Advertisers to Use My Personal information